GAM Holding’s Corcept Therapeutics CORT Stock Holding History

GAM Holding’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,802	Closed	-$128K	–	333
2020 Q1	$128K	Sell	10,802 -10,384	-49%	-$129K	0.01%	312
2019 Q4	$256K	Buy	+21,186	New	+$295K	0.01%	477

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAM Holding's CORT Position: Q2 2020 in Review

GAM Holding sold out of Corcept Therapeutics (CORT) in Q2 2020, closing a stake of 10,802 shares — an estimated $128K sold.

GAM Holding first reported a position in CORT in Q4 2019 and held it in 2 quarters. The position peaked at $256K in Q4 2019. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2020.

GAM Holding reported no remaining Corcept Therapeutics position as of Q2 2020 after selling out during the quarter.
GAM Holding sold 10,802 Corcept Therapeutics shares in Q2 2020, an estimated $128K.
GAM Holding first reported a position in Corcept Therapeutics in Q4 2019 and held it in 2 quarters.
GAM Holding's Corcept Therapeutics position peaked at $256K in Q4 2019.
224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2020.

Based on GAM Holding's 13F filing for Q2 2020, filed 10 Aug 2020.